General MedicationsINTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREALStandard
PORTRAZZA
NECITUMUMAB
Standard Dose
800MG/50ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PORTRAZZA is listed in Drugs@FDA under application 125547 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient NECITUMUMAB Form and strength INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL - 800MG/50ML Sponsor ELI LILLY CO Submission history Latest submission status date: 2015-11-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview PORTRAZZA is listed in Drugs@FDA under application 125547 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient NECITUMUMAB Form and strength INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL - 800MG/50ML Sponsor ELI LILLY CO Submission history Latest submission status date: 2015-11-24 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.